Clinical trial
Randomized and Controlled Trial on the Safety and Efficacy of Bemiparin in the Prevention of Thrombotic Events in Hospitalized Cirrhotic Patients
NCT02802605 is registered in ClinicalTrials.gov with Instituto de Investigación Marqués de Valdecilla as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized and Controlled Trial on the Safety and Efficacy of Bemiparin in the Prevention of Thrombotic Events in Hospitalized Cirrhotic Patients
- Lead sponsor
- Instituto de Investigación Marqués de Valdecilla
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- May 31, 2016
- Completion date
- June 30, 2019
- Enrollment
- 225 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
cirrhosis and coagulation